Irbinitinib,
Tucatinib,
937263-43-9,
ONT-380,
6-DIAMINE,
UNII-234248D0HH,
234248D0HH,
N6-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)quinazoline-4,6-diamine,
N4-(4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)-N6-(4,4-dimethyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine,
Irbitinib,
ONT 380,
Tucatinib (USAN/INN),
Tucatinib [USAN:INN],
Irbinitinib(ARRY-380),
Irbinitinib; ARRY-380,
arry-380-ont-380,
GTPL9922,
SCHEMBL1193050,
CHEMBL3989868,
SDEAXTCZPQIFQM-UHFFFAOYSA-N,
BCP15983,
EX-A1031,
KS-00000TU4,
MFCD22380467,
s8362,
ZINC68250462,
ARRY-380 (ONT-380),
AKOS026750449,
CS-3906,
DB11652,
SB17126,
Irbinitinib (ARRY-380, ONT-380),
4,6-Quinazolinediamine, N6-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-N4-(3-methyl-4-((1,2,4)triazolo(1,5-a)pyridin-7-yloxy)phenyl)-,
AK548135,
BC600725,
HY-16069,
Example 11 [WO2007059257A2],
A16413,
D11141,
4,6-QuinazolinediaMine,N6-(4,5-dihydro-4,4-diMethyl-2-oxazolyl)-N4-[3-Methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-,
6-N-(4,4-dimethyl-5H-1,3-oxazol-2-yl)-4-N-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]quinazoline-4,6-diamine,
N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine,
Arry-380,
Tucatinib [INN],
Arry 380,
(R)-N6-(4-Methyl-4;5-dihydrooxazol-2-yl)-N4-(3-Methyl-4-(thiazol-2-ylMethoxy)phenyl)quinazoline-4;6-diaMine,
4,6-QuinazolinediaMine, N6-(4,5-dihydro-4,4-diMethyl-2-oxazolyl)-N4-[3-Methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-,